Dec 01st 2006 - Edison Investment Research today published a report on Amphion Innovations (AMP.L, LSE:AMP, LON:AMP) entitled "New Investments". In summary, the report says:
Amphion Innovations has made a sigificant investment in Myconostica, a spin-out from the University of Manchester developing a technology for the rapid diagnosis of life-threatening fungal infections. Myconostica will be Amphionâ€™s seventh partner company, its fifth in life sciences, and its second to be based in the UK.
Edison, the investment intelligence firm, is the future of investor interaction with corporates. Our team of over 100 analysts and investment professionals work with leading companies, fund managers and investment banks worldwide to support their capital markets activity. We provide services to more than 400 retained corporate and investor clients from our offices in London, New York, Frankfurt, Sydney and Wellington. Edison is authorised and regulated by the Financial Conduct Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). more »